Latest Administration News

C29 Metals bolstered its Kazakhstan multi-mineral project with a new tenement grant and appointed Dr Robert Stuart as Chief Geoscientist, while maintaining a solid cash position of $1.674 million at quarter end.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.

Vintage Energy reported a dip in quarterly sales and production but achieved cost savings and secured a key permit renewal, positioning itself for a production uplift program despite recent flooding delays.

IPB Petroleum Limited has secured a crucial two-year extension on its WA-424-P permit in the Browse Basin, enabling continued exploration and development of its Gwydion asset while maintaining a solid cash position of AUD 1.487 million.

ADX Energy reported a 13% rise in Austrian production and a 15% increase in sales revenue for Q1 2025, while Welchau-1 well testing remains suspended pending legal review. The company also secured a key Italian gas exploration permit, positioning for growth across Europe.

M3 Mining Limited reports promising early-stage gold exploration results at its Edjudina Project in Western Australia, identifying key mineralisation zones at Broken Hill Bore and Old Plough Dam. Concurrently, its subsidiary advances talks to secure a strategic energy asset in North Africa.

Equity Story Group Ltd reported a robust 56% revenue increase in the March 2025 quarter, driven by strong fund performance and membership growth, alongside a strategic investment and plans to acquire Baker Young Limited.

LCL Resources has struck a binding agreement to divest its Colombian projects for A$10 million plus royalties, while unveiling a maiden 831,000-ounce gold resource at its Kusi project in Papua New Guinea.

Askari Metals has raised $750,000 through a placement to advance its tin, tantalum, and gold projects in Namibia and Ethiopia, positioning itself for growth in African mineral exploration.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.